Literature DB >> 19352090

The inherited genetic component of sporadic pancreatic adenocarcinoma.

R L Milne1, W Greenhalf, C Murta-Nascimento, F X Real, N Malats.   

Abstract

Pancreatic cancer, like many other complex diseases, has genetic and environmental components to its etiology. It is likely that relatively common genetic variants with modest effects on pancreatic cancer risk play an important role in both familial and sporadic forms of the disease, either individually or in interaction with environmental factors. The relatively high frequency of such variants means that they could potentially explain a substantial portion of disease risk. Here we summarize the findings published to date from genetic association studies. In general, very few low-penetrance variants have been identified and those that have require replication in independent studies. Possible gene-environment interactions arising from these studies also require replication. More comprehensive approaches are needed to make progress, including global analyses of biologically sound pathways and genome-wide association studies. Large sample sizes are required to do this appropriately and multi-study consortia make this possible. A number of consortia of pre-existing studies have already been formed, and these will facilitate the identification of further low-penetrance variants and gene-environment interaction. However, these approaches do not substitute for the design of novel, sufficiently powered studies that apply uniform criteria to case selection, the acquisition of environmental exposure information, and to biological sample collection. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352090     DOI: 10.1159/000210261

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  5 in total

1.  Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT).

Authors:  Bruce G Haffty; Sharad Goyal; Diptee Kulkarni; Camille Green; Alexi Vazquez; Devora Schiff; Meena S Moran; Qifeng Yang; Shridar Ganesan; Kim M Hirsfield
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

Review 2.  UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better.

Authors:  Patrick Michl; Matthias Löhr; John P Neoptolemos; Gabriele Capurso; Vinciane Rebours; Nuria Malats; Mathilde Ollivier; Luigi Ricciardiello
Journal:  United European Gastroenterol J       Date:  2021-08-25       Impact factor: 6.866

3.  Genome-wide association study of pancreatic cancer in Japanese population.

Authors:  Siew-Kee Low; Aya Kuchiba; Hitoshi Zembutsu; Akira Saito; Atsushi Takahashi; Michiaki Kubo; Yataro Daigo; Naoyuki Kamatani; Suenori Chiku; Hirohiko Totsuka; Sumiko Ohnami; Hiroshi Hirose; Kazuaki Shimada; Takuji Okusaka; Teruhiko Yoshida; Yusuke Nakamura; Hiromi Sakamoto
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

4.  The role of tobacco-derived carcinogens in pancreas cancer.

Authors:  Rajiv Lochan; Helen L Reeves; Anne K Daly; Richard M Charnley
Journal:  ISRN Oncol       Date:  2011-07-17

5.  Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants.

Authors:  Ali Al-Fatlawi; Negin Malekian; Sebastián García; Andreas Henschel; Ilwook Kim; Andreas Dahl; Beatrix Jahnke; Peter Bailey; Sarah Naomi Bolz; Anna R Poetsch; Sandra Mahler; Robert Grützmann; Christian Pilarsky; Michael Schroeder
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.